Pharma and Healthcare Sector Research

Life-sciences Research

Overview

We enable our life-sciences and healthcare clients better understand the market and competitive landscape, improve efficiencies and productivity, and formulate effective developmental and commercial strategies. Our engagements have been with clients teams within large and mid-tier pharmaceutical, devices and also biotechnology companies operating across the globe. We offer flexible, scalable, and cost-effective strategic research solutions across key pharma domains covering a wide spectrum of therapeutic areas. Our clients have gained tangible business value through our unparalleled domain expertise, customized research offerings, and effective execution capabilities.

Support we offer

Drug Discovery and Development

Corporate Strategy and Research

Product Management, Sales & Marketing

Data Analytics

Procurement

How we are different

Broad spectrum of service offerings supporting a number of functions within pharma, bio-pharma and medical device companies

Long term partnerships to drive efficiency in client operations

Ability to scale up or down based on requirements, both current and future

International delivery centers available to provide round the clock support with multi-lingual capabilities

Structured governance process and high data security through sustained investment from Acuity Knowledge Partners

Integrating data analytics’ capabilities with domain experts providing insights analyzing large unstructured data

What we have done

Support for Consulting and Corporate Firms
Procurement in non-Food FMCG Industry
What we are proud of

10-15%

sourcing cost reductions by

Macro-economics/ regulation

Our perspective on Life-sciences Research
post page Blog
Digital transformation in healthcare

Digitalisation in health..... Read More

September 22, 2020

centric , Digital , discovery

post page Blog
Impact of COVID-19 on the pharma value chain

It is more than five mon..... Read More

June 11, 2020

COVID-19 , effect , impact

post page Blog
China’s PD-1 inhibitor market is becoming more competitive

Programmed cell death pr..... Read More

Thank you for sharing your details

Share this on